Ann Kathryn Korkidakis, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Abortion, Habitual | 1 | 2023 | 69 | 0.900 |
Why?
|
Infertility | 4 | 2022 | 612 | 0.810 |
Why?
|
Embryo Transfer | 2 | 2022 | 513 | 0.800 |
Why?
|
Embryo Implantation | 1 | 2021 | 269 | 0.730 |
Why?
|
Abortion, Induced | 1 | 2023 | 411 | 0.640 |
Why?
|
Anti-Mullerian Hormone | 1 | 2020 | 400 | 0.630 |
Why?
|
Birth Rate | 3 | 2022 | 169 | 0.430 |
Why?
|
Publishing | 1 | 2017 | 824 | 0.370 |
Why?
|
Precancerous Conditions | 1 | 2016 | 960 | 0.340 |
Why?
|
Referral and Consultation | 2 | 2020 | 3416 | 0.300 |
Why?
|
Fertilization in Vitro | 4 | 2022 | 1276 | 0.280 |
Why?
|
Pregnancy Rate | 3 | 2022 | 626 | 0.250 |
Why?
|
Carcinoma | 1 | 2016 | 2341 | 0.240 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2016 | 1966 | 0.240 |
Why?
|
Canada | 2 | 2019 | 1989 | 0.210 |
Why?
|
Early Detection of Cancer | 1 | 2016 | 2957 | 0.210 |
Why?
|
Live Birth | 2 | 2022 | 485 | 0.210 |
Why?
|
Pregnancy | 8 | 2023 | 28145 | 0.180 |
Why?
|
Maternal Age | 1 | 2023 | 799 | 0.180 |
Why?
|
Time-Lapse Imaging | 1 | 2020 | 196 | 0.170 |
Why?
|
Cryopreservation | 1 | 2021 | 631 | 0.150 |
Why?
|
Oocytes | 1 | 2021 | 1209 | 0.140 |
Why?
|
Pregnancy in Adolescence | 1 | 2016 | 156 | 0.120 |
Why?
|
Embryo, Mammalian | 1 | 2020 | 1722 | 0.120 |
Why?
|
Premature Birth | 2 | 2022 | 1619 | 0.120 |
Why?
|
Breast Neoplasms | 1 | 2019 | 20448 | 0.100 |
Why?
|
Lymphoma | 1 | 2020 | 1858 | 0.100 |
Why?
|
Retrospective Studies | 7 | 2023 | 74206 | 0.090 |
Why?
|
Insurance Coverage | 1 | 2021 | 1850 | 0.090 |
Why?
|
Prognosis | 2 | 2021 | 28737 | 0.090 |
Why?
|
Cathepsin D | 1 | 2008 | 63 | 0.080 |
Why?
|
Female | 10 | 2023 | 375449 | 0.080 |
Why?
|
Cathepsins | 1 | 2008 | 284 | 0.070 |
Why?
|
Fertility | 2 | 2021 | 756 | 0.070 |
Why?
|
Cysteine Endopeptidases | 1 | 2008 | 572 | 0.070 |
Why?
|
Birth Weight | 2 | 2022 | 2025 | 0.060 |
Why?
|
Humans | 11 | 2023 | 725187 | 0.060 |
Why?
|
Lysosomes | 1 | 2008 | 906 | 0.060 |
Why?
|
Cost-Benefit Analysis | 1 | 2016 | 5343 | 0.060 |
Why?
|
Birth Intervals | 1 | 2022 | 50 | 0.050 |
Why?
|
Adult | 5 | 2023 | 211615 | 0.050 |
Why?
|
Adolescent | 3 | 2020 | 84401 | 0.050 |
Why?
|
Young Adult | 3 | 2021 | 55781 | 0.040 |
Why?
|
Age Factors | 1 | 2016 | 18339 | 0.040 |
Why?
|
Infant, Small for Gestational Age | 1 | 2021 | 435 | 0.040 |
Why?
|
Infant, Low Birth Weight | 1 | 2022 | 845 | 0.040 |
Why?
|
Follow-Up Studies | 1 | 2019 | 38748 | 0.040 |
Why?
|
Membrane Glycoproteins | 1 | 2008 | 3785 | 0.040 |
Why?
|
Nerve Tissue Proteins | 1 | 2008 | 4501 | 0.030 |
Why?
|
Gestational Age | 1 | 2021 | 3443 | 0.030 |
Why?
|
Infant, Premature | 1 | 2021 | 2013 | 0.030 |
Why?
|
Cathepsin H | 1 | 2008 | 9 | 0.020 |
Why?
|
Receptor, IGF Type 2 | 1 | 2008 | 35 | 0.020 |
Why?
|
Boston | 1 | 2021 | 9288 | 0.020 |
Why?
|
Adaptor Proteins, Vesicular Transport | 1 | 2008 | 317 | 0.020 |
Why?
|
COS Cells | 1 | 2008 | 1187 | 0.020 |
Why?
|
Sequence Deletion | 1 | 2008 | 1547 | 0.010 |
Why?
|
Protein Transport | 1 | 2008 | 2015 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2022 | 24985 | 0.010 |
Why?
|
Ligands | 1 | 2008 | 3282 | 0.010 |
Why?
|
Time Factors | 1 | 2021 | 40186 | 0.010 |
Why?
|
RNA, Small Interfering | 1 | 2008 | 3529 | 0.010 |
Why?
|
Prospective Studies | 1 | 2022 | 51869 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2021 | 61761 | 0.010 |
Why?
|
Risk Factors | 1 | 2021 | 71009 | 0.010 |
Why?
|
United States | 1 | 2021 | 68403 | 0.010 |
Why?
|
Middle Aged | 1 | 2021 | 212292 | 0.000 |
Why?
|
Male | 1 | 2021 | 347096 | 0.000 |
Why?
|
Animals | 1 | 2008 | 168714 | 0.000 |
Why?
|